Ozurdex, intravitreales Implantat in Applikator

7680603240015 CH-60324 intravitreales Implantat in Applikator

Associated product:

OZURDEX intravitréen implant dans applicateur
Ozurdex, intravitreales Implantat in Applikator
Ozurdex, intravitreales Implantat in Applikator
Ozurdex, intravitreales Implantat in Applikator
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
intravitreales Implantat in Applikator
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
18/12/2023
Summary of Product Characteristics
Français
18/12/2023
Summary of Product Characteristics
Italien
18/12/2023

Detailed composition

Substance Quantity Type Category
(N/A)
700.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1051.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2012

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
60324
Drug name
Ozurdex, intravitreales Implantat in Applikator
Galenic form
IMPL
ATC Code
S01BA01
Authorization status
Z
Dispensing category
A
First authorization
10/01/2011
Authorization expiration date
31/12/9999
IT Number
11.99.0.
Domain
Human medicine
Field of application
Makulaödem nach retinalem Venenastverschluss oder Zentralvenenverschluss; Entzündung des posterioren Segments des Auges, die sich als nicht infektiöse Uveitis darstellt, diabetisches Makulaödem

Package details

Description (FR)
OZURDEX intravitréen implant dans applicateur
Description (DE)
OZURDEX intravitreales Implant in Applikator
Market launch
10/01/2011
Narcotic (BTM)
No